Skip to main content
Clinical Trials/ACTRN12619001360101
ACTRN12619001360101
Terminated
未知

Assessing the effect of melatonin on sleep behaviour and executive functioning in children with Fetal Alcohol Spectrum Disorder

Griffith University0 sites9 target enrollmentOctober 3, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Chronic Insomnia Disorder
Sponsor
Griffith University
Enrollment
9
Status
Terminated
Last Updated
2 years ago

Overview

Brief Summary

Data being processed

Registry
who.int
Start Date
October 3, 2019
End Date
September 5, 2022
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Children aged between 5\- and 12\-years with confirmed prenatal alcohol exposure and who have been assessed using the Australian Guidelines for the diagnosis of FASD to have either FASD with 3 Sentinel Facial Features (SFF); FASD with \< 3 SFF or At Risk” of FASD (Bower \& Elliott, 2016\), and with reported sleep problems (see Inclusion Criteria).
  • Sleep Problem Inclusion Criteria
  • Children will be included in the study if their parents/caregivers report that they have problems with sleep initiation, whereby sleep onset latency is equal to or greater than 30 minutes, three nights or more a week, for equal to or more than three months.

Exclusion Criteria

  • 1\) Are not currently receiving sedative medications,
  • 2\) Who have changed place of residence or primary carers in the last three months (as this instability may be contributing to sleep problems independent from FASD).
  • 3\) Have been diagnosed with Type 1 diabetes.

Outcomes

Primary Outcomes

Not specified

Similar Trials